Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta A Toscano

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
The Journal of Biological Chemistry|November 24, 2004
Galectin-1 sensitizes resting human T lymphocytes to Fas (CD95)-mediated cell death via mitochondrial hyperpolarization, budding, and fissionPaola Matarrese, Antonella Tinari, Elisabetta Mormone, et al.
IUBMB Life|December 17, 2009
Dissecting the signal transduction pathways triggered by galectin-glycan interactions in physiological and pathological settingsDiego J Laderach, Daniel Compagno, Marta A Toscano, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2006
A novel function for galectin-1 at the crossroad of innate and adaptive immunity: galectin-1 regulates monocyte/macrophage physiology through a nonapoptotic ERK-dependent pathwayPaula Barrionuevo, Macarena Beigier-Bompadre, Juan M Ilarregui, et al.
Molecular and Cellular Biochemistry|January 25, 2005
Regulated expression of galectin-1 during T-cell activation involves Lck and Fyn kinases and signaling through MEK1/ERK, p38 MAP kinase and p70S6 kinaseMercedes B Fuertes, Luciana L Molinero, Marta A Toscano, et al.
Cancer Immunology, Immunotherapy : CII|May 31, 2006
Low-dose cyclophosphamide modulates galectin-1 expression and function in an experimental rat lymphoma modelMariano F Zacarías Fluck, María J Rico, Silvia I Gervasoni, et al.
Nature Immunology|August 12, 2009
Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10Juan M Ilarregui, Diego O Croci, Germán A Bianco, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 3, 2010
Lack of TNFR p55 results in heightened expression of IFN-γ and IL-17 during the development of reactive arthritisRicardo J Eliçabe, Ethelina Cargnelutti, María I Serer, et al.
Cancer Cell|March 31, 2004
Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilegeNatalia Rubinstein, Mariano Alvarez, Norberto W Zwirner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2006
Galectin-1 suppresses autoimmune retinal disease by promoting concomitant Th2- and T regulatory-mediated anti-inflammatory responsesMarta A Toscano, Alessandra G Commodaro, Juan M Ilarregui, et al.
Glycobiology|December 18, 2004
Galectin-3 and soluble fibrinogen act in concert to modulate neutrophil activation and survival: involvement of alternative MAPK pathwaysGabriela C Fernández, Juan M Ilarregui, Carolina J Rubel, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
The Journal of Biological Chemistry|November 24, 2004
Galectin-1 sensitizes resting human T lymphocytes to Fas (CD95)-mediated cell death via mitochondrial hyperpolarization, budding, and fissionPaola Matarrese, Antonella Tinari, Elisabetta Mormone, et al.
IUBMB Life|December 17, 2009
Dissecting the signal transduction pathways triggered by galectin-glycan interactions in physiological and pathological settingsDiego J Laderach, Daniel Compagno, Marta A Toscano, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2006
A novel function for galectin-1 at the crossroad of innate and adaptive immunity: galectin-1 regulates monocyte/macrophage physiology through a nonapoptotic ERK-dependent pathwayPaula Barrionuevo, Macarena Beigier-Bompadre, Juan M Ilarregui, et al.
Molecular and Cellular Biochemistry|January 25, 2005
Regulated expression of galectin-1 during T-cell activation involves Lck and Fyn kinases and signaling through MEK1/ERK, p38 MAP kinase and p70S6 kinaseMercedes B Fuertes, Luciana L Molinero, Marta A Toscano, et al.
Cancer Immunology, Immunotherapy : CII|May 31, 2006
Low-dose cyclophosphamide modulates galectin-1 expression and function in an experimental rat lymphoma modelMariano F Zacarías Fluck, María J Rico, Silvia I Gervasoni, et al.
Nature Immunology|August 12, 2009
Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10Juan M Ilarregui, Diego O Croci, Germán A Bianco, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 3, 2010
Lack of TNFR p55 results in heightened expression of IFN-γ and IL-17 during the development of reactive arthritisRicardo J Eliçabe, Ethelina Cargnelutti, María I Serer, et al.
Cancer Cell|March 31, 2004
Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilegeNatalia Rubinstein, Mariano Alvarez, Norberto W Zwirner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2006
Galectin-1 suppresses autoimmune retinal disease by promoting concomitant Th2- and T regulatory-mediated anti-inflammatory responsesMarta A Toscano, Alessandra G Commodaro, Juan M Ilarregui, et al.
Glycobiology|December 18, 2004
Galectin-3 and soluble fibrinogen act in concert to modulate neutrophil activation and survival: involvement of alternative MAPK pathwaysGabriela C Fernández, Juan M Ilarregui, Carolina J Rubel, et al.
Pageof 5